Group One Trading’s Edgewise Therapeutics EWTX Stock Holding History

Group One Trading’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$183K	Sell	4,500 -18,000	-80%	-$621K	﹤0.01%	4357
2026 Q1	$709K	Sell	22,500 -16,500	-42%	-$476K	﹤0.01%	3017
2025 Q4	$968K	Buy	39,000 +31,000	+388%	+$622K	﹤0.01%	2923
2025 Q3	$130K	Buy	8,000 +4,300	+116%	+$61K	﹤0.01%	5100
2025 Q2	$48.5K	Sell	3,700 -3,200	-46%	-$46.1K	﹤0.01%	5599
2025 Q1	$152K	Sell	6,900 -100	-1%	-$2.62K	﹤0.01%	4243
2024 Q4	$187K	Sell	7,000 -25,400	-78%	-$809K	﹤0.01%	3984
2024 Q3	$865K	Buy	32,400 +25,000	+338%	+$497K	﹤0.01%	2424
2024 Q2	$133K	Sell	7,400 -100	-1%	-$1.74K	﹤0.01%	3724
2024 Q1	$137K	Sell	7,500 -3,700	-33%	-$58.8K	﹤0.01%	3873
2023 Q4	$123K	Buy	+11,200	New	+$78.6K	﹤0.01%	4284

Other funds holding EWTX

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Group One Trading's EWTX Position: Q2 2026 in Review

Group One Trading opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 4,477 shares worth $182K. The stake represents ﹤0.01% of the portfolio and ranks #4360 among its holdings. This is a return to the name: Group One Trading previously reported a position in EWTX as recently as Q1 2025.

Group One Trading first reported a position in EWTX in Q2 2023 and has held it in 4 quarters since. The position peaked at $278K in Q1 2025. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

Group One Trading held 4,477 shares of Edgewise Therapeutics worth $182K as of Q2 2026.
Edgewise Therapeutics was a new Group One Trading position in Q2 2026.
Edgewise Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4360 holding.
Group One Trading first reported a position in Edgewise Therapeutics in Q2 2023 and has held it in 4 quarters since.
Group One Trading's Edgewise Therapeutics position peaked at $278K in Q1 2025.
226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.